These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16091906)

  • 1. HIV genetic diversity: any implications for drug resistance?
    Jülg B; Goebel FD
    Infection; 2005 Aug; 33(4):299-301. PubMed ID: 16091906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of HIV-1 pol diversity on drug resistance and its clinical implications.
    Kantor R
    Curr Opin Infect Dis; 2006 Dec; 19(6):594-606. PubMed ID: 17075337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
    Sukasem C; Churdboonchart V; Sukeepaisarncharoen W; Piroj W; Inwisai T; Tiensuwan M; Chantratita W
    Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.
    Vázquez de Parga E; Rakhmanova A; Pérez-Alvarez L; Vinogradova A; Delgado E; Thomson MM; Casado G; Sierra M; Muñoz M; Carmona R; Vega Y; Contreras G; Medrano L; Osmanov S; Nájera R
    J Med Virol; 2005 Nov; 77(3):337-44. PubMed ID: 16173024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries.
    Obiako OR; Murktar HM; Ogoina D
    Niger J Med; 2010; 19(3):302-10. PubMed ID: 20845636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors.
    Brennan CA; Stramer SL; Holzmayer V; Yamaguchi J; Foster GA; Notari Iv EP; Schochetman G; Devare SG
    Transfusion; 2009 Jan; 49(1):125-33. PubMed ID: 18954404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrase polymorphism and HIV-1 group O diversity.
    Leoz M; Depatureaux A; Vessière A; Roquebert B; Damond F; Rousset D; Roques P; Simon F; Plantier JC;
    AIDS; 2008 Jun; 22(10):1239-43. PubMed ID: 18525277
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
    Vergne L; Stuyver L; Van Houtte M; Butel C; Delaporte E; Peeters M
    J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns among treatment-naive patients in different stages of infection in Rio de Janeiro, Brazil.
    Varella RB; Ferreira SB; de Castro MB; Zalis MG; Tavares MD
    J Med Virol; 2007 Aug; 79(8):1033-9. PubMed ID: 17596836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes.
    Holguín A; Ramirez de Arellano E; Rivas P; Soriano V
    AIDS Rev; 2006; 8(2):98-107. PubMed ID: 16848277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
    Nadembega WM; Giannella S; Simpore J; Ceccherini-Silberstein F; Pietra V; Bertoli A; Pignatelli S; Bellocchi MC; Nikiema JB; Cappelli G; Bere A; Colizzi V; Perno CP; Musumeci S
    J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.
    Escoto-Delgadillo M; Vázquez-Valls E; Ramírez-Rodríguez M; Corona-Nakamura A; Amaya-Tapia G; Quintero-Pérez N; Panduro-Cerda A; Torres-Mendoza BM
    HIV Med; 2005 Nov; 6(6):403-9. PubMed ID: 16268822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
    Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
    J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola.
    Garrido C; Zahonero N; Fernándes D; Serrano D; Silva AR; Ferraria N; Antúnes F; González-Lahoz J; Soriano V; de Mendoza C
    J Antimicrob Chemother; 2008 Mar; 61(3):694-8. PubMed ID: 18218644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
    Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type-1 transmission dynamics in recent seroconverters: relationship with transmission of drug resistance and viral diversity.
    Recordon-Pinson P; Anies G; Bruyand M; Neau D; Morlat P; Pellegrin JL; Groppi A; Thiébaut R; Dabis F; Fleury H; Masquelier B;
    Antivir Ther; 2009; 14(4):551-6. PubMed ID: 19578240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.